A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma-Reference-Cited by-同舟云学术

A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma

Published:2008 Issue:2 Volume:112 Page:331-339
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Downs Levi S.,Judson Patricia L.,Argenta Peter A.,Ghebre Rahel,Geller Melissa A.,Bliss Robin L.,Boente Matthew P.,Nahhas William A.,Abu-Ghazaleh Samir Z.,Chen M. Dwight,Carson Linda F.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference27 articles.

1. American Cancer Society. Cancer Facts and Figures 2007. Atlanta, Ga: American Cancer Society; 2006.

2. Effects of Thalidomide and Related Metabolites in a Mouse Corneal Model of Neovascularization

3. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.

4. Thalidomide: Emerging Role in Cancer Medicine

5. Selection of Novel Analogs of Thalidomide with Enhanced Tumor Necrosis Factor α Inhibitory Activity

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted therapy and molecular genetics;DiSaia and Creasman Clinical Gynecologic Oncology;2023

2. Efficacy of non‑platinum chemotherapy in platinum‑resistant ovarian cancer: a meta‑analysis;Malignant tumours;2022-04-08

3. Synergism of AZD6738, an ATR Inhibitor, in Combination with Belotecan, a Camptothecin Analogue, in Chemotherapy-Resistant Ovarian Cancer;International Journal of Molecular Sciences;2021-01-27

4. Efficacy and Safety of Thalidomide for Chemotherapy-induced Nausea and Vomiting;Journal of Cancer;2020

5. Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience;Journal of Oncology;2019-03-20